Category: ACN Newswire

HONG KONG, Sep 29, 2025 - 28 September, The world's first 9,300 CEU methanol dual-fuel Pure Car and Truck Carrier (PCTC), "CM HONG KONG", celebrated its maiden voyage with a ceremony in Tsing Yi, Hong Kong. Vice-chairperson of the National Committee of the Chinese People's Political Consultative Conference, Leung Chun-ying, Chief Secretary for Administration of the HKSAR, Chan Kwok-kei, Deputy Director of the Liaison Office of the Central People's Government in the HKSAR, Qi Bin, and Chairman of China Merchants Group Limited, Miao Jianmin, etc. attended the ceremony, with Executive Vice President of China Merchants Group Limited, Deng Renjie, as the master of ceremonies.During the event, a commemorative plaque was presented to the ship's captain. Guests toured the vessel's bridge, crew quarters, and innovative methanol dual-fuel system, witnessing its advancements in low-carbon technology and operational efficiency.Built for China Merchants Energy Shipping (CMES), "CM HONG KONG" is the first large-scale car carrier powered by a methanol dual-fuel system, enabling seamless switching between conventional fuel and methanol. Compliant with IMO Tier III emission standards, it achieves over 70% emissions reduction when using green methanol. The ship, measuring 219.9 meters long and 37.7 meters wide, has a design capacity of 9,300 CEUs, with an actual capacity of up to 9,492 CEUs. Its 78,416-square-meter loading area, equivalent to 11 football fields, features 13 decks, including three adjustable lift decks and three tailored for hydrogen fuel cell vehicles. Dual stern and side ramps boost loading/unloading efficiency by 30%. Safety is enhanced with 156 CCTV cameras and thermal imaging infrared sensors across all decks."CM HONG KONG" embarked on its inaugural China-to-Europe route, unloading vehicles in Hong Kong before heading to Europe. Leveraging Hong Kong's free port status, CMES aims to advance the "green fuel trade + port services" model, fostering economic growth, attracting international vessels for green fuel bunkering, and strengthening Hong Kong's role as a global green maritime hub.Vice-chairperson of the National Committee of the Chinese People's Political Consultative Conference, Leung Chun-ying, delivered a speech at the ceremony.Chief Secretary for Administration of the HKSAR, Chan Kwok-kei, delivered a speech at the ceremony.Chairman of China Merchants Group Limited, Miao Jianmin, delivered a speech at the ceremony. Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港，2025年9月29日 - (亞太商訊 via SeaPRwire.com) - 9月28日，全球首艘9300CEU（標準車位）甲醇雙燃料動力滾裝船"CM HONG KONG"輪（中文名"港榮"輪）首航香港儀式在香港青衣舉行。全國政協副主席梁振英、香港特區政府政務司司長陳國基、中央政府駐港聯絡辦副主任祁斌、招商局集團董事長繆建民等出席，招商局集團副總經理鄧仁傑主持。梁振英在致辭時表示，"CM HONG KONG"輪是高新科技與香港航運發展的深度融合，標誌香港國際航運中心地位的提升，寄託了對香港繁榮穩定的美好願景。招商局集團作為香港歷史悠久的中資企業，始終與國家發展大局同頻共振，推動香港經濟社會繁榮發展。希望招商局集團持續創新，為香港和國家長遠發展貢獻力量。陳國基表示，招商局集團一直積極配合特區政府政策，走在綠色轉型的前線。"港榮"輪使用可以減少七成以上溫室氣體排放的綠色燃料，充分體現科技創新和環保理念的深度融合。期盼招商局集團繼續深耕香港、貢獻香港發展，在建設國際金融、航運、貿易三中心，以及國際高端人才集聚高地方面，發揮更大作用。繆建民表示，招商局集團與香港共榮共生，積極助力香港航運業高品質發展。"CM HONG KONG"輪冠以香港之名，承載繁榮祝願，更是招商局集團紮根香港的生動注腳。未來，招商局集團將加快綠色船舶建設，持續提升世界航商大會平台影響力，推動港航物流綠色化，助力香港打造全球航運業綠色低碳發展新樣本。儀式上，香港海事處處長王世發向"CM HONG KONG"輪船長頒發紀念牌。嘉賓們隨後登船參觀駕駛台、生活區及甲醇雙燃料動力系統，體驗該輪在低碳技術與裝載效率上的突破。有關機構嘉賓、招商局集團有關部門和二級公司負責人參加活動。"CM HONG KONG"輪由招商輪船訂造，是全球首艘採用甲醇雙燃料動力系統的大型汽車滾裝船。動力系統支援燃油與甲醇靈活切換，滿足國際海事組織Tier Ⅲ排放標準，使用綠色甲醇時可減排超70%。該船總長219.9米，型寬37.7米，設計裝載容量9300個標準車位元，實際可達9492個。總裝車面積78416平方米，約相當於11個標準足球場。配備13層裝載甲板，其中3層為可調節升降甲板，另有3層專為氫燃料電池車設計。尾跳與側跳雙裝卸通道提升裝卸效率30%。全船配備156個閉路電視監控系統，13層甲板均設耦合熱成像紅外探頭，確保安全。"CM HONG KONG"輪首航執行中國至歐洲航線，在香港卸車後將駛往歐洲。招商輪船將充分利用香港自由港的獨特優勢，參與推動香港"綠色燃料貿易+港口服務"模式，助力打造新的經濟增長點，吸引更多國際船舶來港加注綠色燃料，為香港綠色航運樞紐的發展注入新動能。 Copyright 2025 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

SINGAPORE, Sept 29, 2025 - (ACN Newswire via SeaPRwire.com) - The future arrived today in Singapore as the World Quantum Summit 2025 (WQS) — themed “Quantum Unboxed: Extending the Reach of AI” — concluded at the Sheraton Towers Singapore with a full house attendance filling the ballroom to capacity. The overwhelming turnoutunderscored the growing global appetite for practical quantum solutions that extend the power of artificial intelligence and accelerate its real-world impact.This year’s summit was not a standalone event but the culmination of a three-day intensive journey into the future of computing and intelligence. On 23–24 September, participants took part in a sold-out Executive Workshop on Quantum and AI, which built foundational understanding of quantum principles, emerging architectures, and integration strategies. The final day brought it all together, showcasing how those concepts are now being deployed in industry — from real-world applications to large-scale investment strategies.Unlike traditional conferences focused solely on research or theory, WQS 2025 brought together the entire ecosystem driving quantum innovation forward. The summit featured practitioners representing different quantum approaches, policy makers, venture investors, academics, corporates, researchers, and ecosystem partners — all converging under one roof to chart the path from lab breakthroughs to industry-scale adoption. On the exhibition floor, leading players such as ST Engineering, QBoson, and TM Research & Development showcased quantum - enhanced solutions in optimisation, secure computing, and AI acceleration. Meanwhile, Gold Capital Network Partners — IMGT and IWC Management — hosted curated sessions connecting founders and investors to accelerate funding into quantum ventures poised for growth.A key highlight was the line-up of 19 world-class speakers, each offering cutting-edge insights into how quantum is transforming the AI landscape. Among them were Assoc. Prof. Mile Gu, Deputy Director of the Nanyang Quantum Hub at Nanyang Technological University; Jeremy Woo, Senior Technical Advisor at D-Wave System; Deepak Waghmare, CTO (APJC) of Dell Technologies; Ujjwal Kumar, Principal Architect, Office of the CTO at Microsoft Asia; Dr. Simon See, Senior Director and Global Head of the NVIDIA AI Technology Center; Bruno Aznar Martinez, R&D Software Developer at Keysight Technologies; Raghunath Koduvayur, CEO of RAQS Quantum; Gao Qi, Algorithm Director at QBoson; Ken Chew, CEO and Partner of IWC Management; and Tony Gu, General Partner at NGC Ventures. They were joined by Ong Yongcheng of Insignia Ventures, Dr. Amelia Tan of ST Engineering, Eric Lee of Deloitte Southeast Asia, Atsushi Sugiura of Oxford Quantum Circuits, Hidetoshi Matsumura of Fujitsu Limited, Ray Han of SAP, Duleesha Kulasooriya of Deloitte, Manisha Sharma Kohli of Google, and Simon Lawrie of AWS.Throughout the summit, a clear narrative emerged: quantum computing has moved beyond theory into strategic deployment, offering a powerful multiplier for AI. Industry leaders showcased case studies where quantum-enhanced AI is already delivering breakthrough results — from accelerating molecular simulations and optimising financial portfolios to solving supply chainchallenges previously considered intractable. Discussions highlighted how enterprises are integrating quantum capabilities directly into their AI workflows, achieving dramatic improvements in processing power, speed, efficiency, and cost-to-insight.The summit also reflected the shifting investment landscape. As quantum technologies mature, institutional and venture capital investors are moving rapidly to back companies with commercially viable products and near-term revenue potential. “Quantum is no longer the future — it’s today’s most powerful strategic edge and already seeing some real applications,” said Ken Chew, CEO of IWC Management. “The confluence of quantum and AI and their cross-synergies are powerful and those who integrate it into their AI stack early will potentially define the competitive landscape of the next decade.”By the close of the event, one message was clear: quantum will not replace AI — it will supercharge it. With practitioners, investors, policymakers, and researchers now aligned on the urgency of adoption, the era of practical quantum applications is no longer a distant vision — it is here, and it is redefining howindustries think about computation, intelligence, and innovation.The World Quantum Summit has firmly established itself as Asia’s premier platform for quantum commercialisation, bridging science, industry, and capital to accelerate real-world adoption. With its unique focus on applications over abstraction and its ability to convene the full quantum ecosystem, WQS is not just a conference — it is a catalyst for the next wave of technological transformation.Media Contact:Eric KhooConference Director, TPGI Pte Ltderic.khoo@pinnaclegroup.global+65 8383 2480 Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港衛生署受理多格列艾汀的新藥上市許可申請（NDA），多格列艾汀是全球首個獲批的葡萄糖激酶激活劑（GKA）基于中國大陸的上市批准，以及强大的III期臨床研究和真實世界臨床結果，多格列艾汀顯示出持久的血糖控制和安全性香港將成爲華領醫藥向東南亞及全球拓展的重要支點上海，2025年9月29日 - (亞太商訊 via SeaPRwire.com) - 華領醫藥（"公司"，香港聯交所股份代號：2552）宣佈，中國香港特別行政區衛生署已正式受理多格列艾汀（dorzagliatin）的新藥上市許可申請（NDA）。多格列艾汀是世界上第一個獲批准用于治療2型糖尿病（T2D）的葡萄糖激酶激活劑（GKA）。此次NDA被受理是華領醫藥拓展中國大陸以外市場戰略的一個重要里程碑，有望將其創新的疾病療法帶給更多亞洲患者，幷最終推向全球市場。香港有超過50萬人患有糖尿病，亞洲有近2.4億人患有糖尿病，多格列艾汀的NDA是解决該地區最緊迫的健康挑戰之一的重要一步。一款具有全球潜力的首創療法多格列艾汀于2022年9月獲得中國國家藥品監督管理局（NMPA）的上市批准，獲批兩個適應症：1）單獨用藥治療未經藥物治療的2型糖尿病患者，可以用于一綫治療；2）在單獨使用鹽酸二甲雙胍血糖控制不佳時，與鹽酸二甲雙胍聯合使用，改善成人2型糖尿病患者的血糖控制。與傳統的降糖藥物不同，多格列艾汀通過修復人體的葡萄糖傳感器--葡萄糖激酶（GK）的功能，直擊血糖調節异常的根源。通過恢復葡萄糖敏感性，多格列艾汀有助于維持血糖平衡，幷支持疾病的長期管理。在中國開展的兩項III期注册臨床研究結果顯示，多格列艾汀能顯著且持續地降低糖化血紅蛋白（HbA1c）水平，改善胰島β細胞功能，降低胰島素抵抗，同時具有良好的安全性和耐受性。目前正在進行的真實世界研究進一步驗證了這些發現，其中部分中期分析結果和數據已在2025年美國糖尿病協會（ADA）科學年會上公佈。通往新市場的戰略門戶作爲地區的醫療和金融樞紐，香港地區在糖尿病社區管理中已形成了一套較爲完善且行之有效的體系。香港中文大學香港糖尿病及肥胖症研究所的研究成果顯示，推行社區爲本的公私營協作糖尿管理模式成效顯著。香港地區的先進經驗對提升糖尿病患者生活質量、控制病情發展及减輕醫療負擔具有重要意義，待多格列艾汀在香港獲批，也將爲産品的糖尿病個性化管理提供更豐富的臨床應用經驗。香港過去的新藥審批制度規定，申請人須向管理局提供由兩個或以上認可國家的藥物監管機關發出的新藥注册證明文件，以及其他規定的相關文件，才能支持該産品的審批上市。但在新設的"1+"機制下，在符合本地臨床數據支持等要求，幷經本地專家認可新藥的適用範圍後，只須提交一個（而非原來的兩個）參考藥物監管機構的許可，便可以在香港申請注册。該制度最早適用于治療嚴重或罕見疾病的新藥，2024年開始擴展至所有新藥。在集團運營和大灣區發展部副總裁曹蓓莉女士的領導下，華領醫藥積極與香港當地臨床專家和監管部門進行了充分且深入的溝通，成爲這一政策的早期探路者。華領醫藥在7月底順利完成多格列艾汀的新藥遞交申請，幷于9月底正式受理。華領醫藥創始人兼CEO陳力博士表示："多格列艾汀在香港的NDA獲得受理，不僅是對多格列艾汀臨床價值的認可，也是華領醫藥國際化進程中的重要一步。香港是地區醫療領域的引領者和金融樞紐，其獨特的地位使其成爲將多格列艾汀的影響力拓展至東南亞及其他地區的理想門戶。我們會繼續與香港本地醫生及合作夥伴携手探索多格列艾汀在糖尿病前期、糖尿病早期治療和預防等方面的潜力，讓全球更多患者能從這一突破性療法中獲益。"多格列艾汀：一款變革性的2型糖尿病治療藥物多格列艾汀于2022年9月在中國大陸獲批，幷被納入2024年1月1日正式執行的國家醫保藥品目錄。多格列艾汀可作爲新診斷患者的一綫單藥治療藥物，也可在二甲雙胍單獨用藥血糖控制不佳時與二甲雙胍聯合使用，用于治療成人2型糖尿病。與許多其它已獲批的口服抗糖尿病藥物不同，腎功能不全患者使用該藥物無需調整劑量。其作用機制是修復人體的葡萄糖傳感器--葡萄糖激酶，恢復葡萄糖敏感性和長期血糖平衡。多格列艾汀可以作用于多個關鍵器官：刺激胰腺分泌胰島素、促進腸道分泌GLP-1、調節肝臟中的糖原。這種多靶點的作用方式可以直擊2型糖尿病的根源，而非僅僅緩解其症狀。此次在香港地區的NDA申請基于兩項在中國開展的多格列艾汀單藥以及聯合二甲雙胍治療 T2D 患者的 III 期注册臨床研究結果。兩項研究表明，針對新診斷未用藥和二甲雙胍足量治療失效的兩類2型糖尿病患者，通過修復GK的傳感器功能缺陷，多格列艾汀能够持續、有效降低患者的HbA1c水平，顯著降低餐後兩小時血糖值（PPG），在無低血糖條件下血糖達標率高，具有良好的安全性和耐受性，幷且能够持續改善β細胞功能和降低胰島素抵抗。前瞻性聲明本文包含有關華領醫藥以及産品未來預期、計劃和前景的陳述。該等前瞻性陳述僅與本文作出該陳述當日的事件或資料有關，可能因未來發展而出現變動。除法律規定外，于作出前瞻性陳述當日之後，無論是否出現新資料、未來事件或其他情况，我們幷無責任更新或公開修改任何前瞻性陳述及預料之外的事件。請仔細閱讀本文幷理解，由于各種風險、不確定性或其他法定要求我們的實際未來業績或表現可能與預期有重大差异。關于華領華領醫藥（"本公司"）是一家總部位于中國上海的創新藥物研發和商業化公司，在美國、中國香港設立了公司。華領醫藥專注于未被滿足的醫療需求，爲全球患者開發全新療法。華領醫藥匯聚全球醫藥行業高素質人才，融合全球創新技術，依托全球優勢資源，研究開發突破性的技術和産品，引領全球糖尿病醫療創新。公司核心産品華堂寧®（多格列艾汀片）以葡萄糖傳感器葡萄糖激酶爲靶點，提升2型糖尿病患者的葡萄糖敏感性，改善患者血糖穩態失調。2022年9月30日，華堂寧®已獲得中國國家藥品監督管理局（NMPA）的上市批准，用于單獨用藥或者與二甲雙胍聯合用藥，治療成人2型糖尿病。對于腎功能不全患者，無需調整劑量，是一款可用于腎功能損傷的2型糖尿病患者的口服降糖藥物。詳情垂詢華領醫藥網址：www.huamedicine.com投資者電郵：ir@huamedicine.com媒體電郵：pr@huamedicine.com Copyright 2025 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Hong Kong Department of Health accepts NDA for dorzagliatin, the world’s first approved glucokinase activator (GKA).Builds on China approval and strong Phase III and real-world clinical results showing durable glucose control and safety.Positions Hong Kong as a strategic gateway for Hua Medicine’s global expansion into Southeast Asia and beyond.SHANGHAI, Sept 29, 2025 - (ACN Newswire via SeaPRwire.com) - Hua Medicine (“the Company”, HKEX: 2552) announced that the Department of Health of the Hong Kong Special Administrative Region of China accepted a New Drug Application (NDA) for dorzagliatin, the world’s first glucokinase activator (GKA) approved for the treatment of Type 2 diabetes (T2D).The acceptance of the NDA marks an important milestone in Hua Medicine’s strategy to expand beyond China, bringing its innovative, disease-modifying treatment to more patients across Asia and ultimately to global markets.With more than half a million people living with diabetes in Hong Kong and nearly 240 million across Asia, the NDA represents a significant step toward addressing one of the region’s most urgent health challenges.A first-in-class therapy with global potentialDorzagliatin was approved for marketing by the China National Medical Products Administration (NMPA) in September 2022 for two indications, both to improve blood glucose control for T2D patients, 1) It can be used as mono-treatment for drug-naïve T2D patients, as first-line treatment, 2) When metformin hydrochloride alone has poor blood glucose control, it can be used in combination with metformin hydrochloride. Unlike conventional drugs that manage symptoms, dorzagliatin targets the root cause of blood sugar dysregulation by repairing the function of glucokinase (GK), the body’s glucose sensor. By restoring glucose sensitivity, dorzagliatin helps maintain blood sugar balance and supports long-term disease management.Results from two Phase III registration trials in China demonstrated that dorzagliatin significantly and sustainably lowered HbA1c levels, improved pancreatic β-cell function, and reduced insulin resistance, all while showing strong safety and tolerability. Findings are being further validated in ongoing real-world studies, of which some interim analysis and data were presented at the 2025 American Diabetes Association (ADA) Scientific Sessions.Strategic gateway to new marketsHong Kong has established a comprehensive, community-based system for diabetes management and serves as a medical and financial hub for the region. Research findings from the Hong Kong Diabetes and Obesity Research Institute at The Chinese University of Hong Kong indicate that the implementation of a community-based public-private collaboration model for diabetes management provided significant benefits to the community. The advanced experience in Hong Kong is of great significance for improving the quality of life of diabetes patients, controlling the progression of the disease, and reducing the burden on the healthcare system. Once approved in Hong Kong, it will also provide clinical application of dorzagliation for the personalized management of diabetes.According to Hong Kong's former new drug approval mechanism, applicants were required to submit to the authority new drug registration certificates issued by the drug regulatory agencies of two or more recognized countries, as well as other specified relevant documents, in order to support the approval and marketing of the product. Under the newly established "1+" mechanism, after meeting requirements such as local clinical data support and having the applicable scope of the new drug endorsed by local experts, an applicant only needs to submit the approval from one (instead of the original two) reference drug regulatory authority to apply for registration of the new drug in Hong Kong. This mechanism initially applied to new drugs for the treatment of serious or rare diseases, and has been extended to all new drugs since 2024.Under the leadership of Ms. Beili Cao, Vice President of Department of Corporate Operation and Great Bay Development, Hua Medicine has conducted sufficient and in-depth communications with local clinical experts and regulatory authorities in Hong Kong, and became an early pioneer of this mechanism. The Company filed its application for registration of dorzagliatin in Hong Kong at the end of July, and the application was officially accepted by the end of September.Dr. Li Chen, Founder and Chief Executive Officer of Hua Medicine, said: “Acceptance of dorzagliatin’s NDA in Hong Kong is not only recognition of its clinical value but also a pivotal step in Hua Medicine’s international journey. Hong Kong’s unique position as a regional healthcare leader and financial hub makes it the ideal gateway for expanding dorzagliatin’s reach into Southeast Asia and beyond. We are committed to working with local doctors and partners in Hong Kong to explore dorzagliatin’s potential in both treatment and prevention of prediabetes and early-stage diabetes, ensuring more patients worldwide can benefit from this breakthrough therapy.”Dorzagliatin: A transformative T2D treatmentDorzagliatin was approved in September 2022 in China, and it was included in the country’s National Reimbursement Drug List (NRDL) as of January 1, 2024.Dorzagliatin can be used alone as a first-line therapy for newly diagnosed patients, or together with metformin when blood sugar control is inadequate. Unlike many other approved oral antidiabetes drugs, no dose adjustment is required for patients with kidney impairment. It works by repairing the body’s glucose sensor, glucokinase (GK), restoring glucose sensitivity and long-term blood sugar balance. It acts across key organs—stimulating insulin secretion in the pancreas, boosting GLP-1 secretion in the gut, and regulating glycogen in the liver. This multi-target approach addresses the root cause of Type 2 diabetes, not just its symptoms.The NDA application in Hong Kong is based on the results of two Phase III registration clinical studies conducted in China evaluating the use of dorzagliatin monotherapy and in combination with metformin for the treatment of patients with Type 2 diabetes. Two studies have shown that for two categories of T2D patients—those newly diagnosed and not yet on medication, and those who have failed to respond adequately to metformin therapy— dorzagliatin can sustainably and effectively lower patients' HbA1c levels by repairing defects in the glucose sensor function of GK, significantly reduce postprandial two-hour blood glucose levels (2h-PPG), achieve high glycemic control rates without hypoglycemia, demonstrate good safety and tolerability, and continuously improve β-cell function and reduce insulin resistance.Forward-Looking StatementsThis document contains statements regarding Hua Medicine’s future expectations, plans, and prospects for the Company and its products. These forward-looking statements pertain only to events or information as of the date they are made and may change due to future developments. Unless required by law, we are not obligated to update or publicly revise any forward-looking statements or unexpected events after the date of such statements, regardless of new information, future events, or other circumstances. Please read this document carefully and understand that our actual future performance or results may differ materially from expectations due to various risks, uncertainties, or other legal requirements.About Hua MedicineHua Medicine (The “Company”) is an innovative drug development and commercialization company based in Shanghai, China, with companies in the United States and Hong Kong. Hua Medicine focuses on developing novel therapies for patients with unmet medical needs worldwide. Based on global resources, Hua Medicine teams up with global high-calibre people to develop breakthrough technologies and products, which contribute to innovation in diabetes care. Hua Medicine's cornerstone product HuaTangNing (dorzagliatin tablets), targets the glucose sensor glucokinase, restores glucose sensitivity in T2D patients, and stabilizes imbalances in blood glucose levels in patients. HuaTangNing was approved by the National Medical Products Administration (NMPA) of China on September 30th, 2022. It can be used alone or in combination with metformin for adult T2D patients. For patients with chronic kidney disease (CKD), no dose adjustment is required. It is an oral hypoglycemic drug that can be used for patients with Type 2 diabetes with renal function impairment.For more informationHua MedicineWebsite: www.huamedicine.comInvestorsWebsite: ir@huamedicine.comMediaWebsite: pr@huamedicine.com Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

東京，2025年9月29日 - (亞太商訊 via SeaPRwire.com) - 據Quantum Solutions Co.,Ltd.（東京證券交易所代碼：2338，下稱「Quantum Solutions」）於2025年9月26日發布的公告顯示，公司已啟動超260億日圓（約1.8億美元）的戰略融資計劃，首輪募集金額達221億日圓（約1.5億美元），公告列出三家國際機構資本參與。這一消息一經公布，隨即引發廣泛關注。觀察人士指出，對日本投資者而言，這是繼巴菲特入股五大商社後，多家美國機構資本對日本資本市場的又一次深度押注；對國際投資者而言，這則意味著日本市場正加速向全球創新資本開放，迎來全新價值重估機會。多家國際機構資本同台亮相，日本市場再獲國際加持本輪融資的投資者組合被部分市場人士稱為「國際資本夢幻陣容」。由Cathie Wood主導的ARK Invest首度將版圖拓展至亞洲，被市場視為其在美國之外的重要戰略突破。ARK長期以來以精準捕捉破壞式創新與新興科技趨勢聞名，市場人士認為，ARK的此次入局被解讀為對Quantum Solutions戰略定位的高度認可，也折射出國際創新資本對日本市場的積極態度。與此同時，全球最大量化交易與專業投資集團之一的SIG（Susquehanna International Group），據公開資料，透過旗下CVI Investments出手，其資本市場經驗與風控能力被認為可為Quantum Solutions後續的流動性管理與資本效率優化提供制度性支持。第三位參與者則是由任德章（TC Yam）先生領導的Integrated Asset Management（IAM）。IAM結合國際金融與媒體資源的跨界優勢，被部分觀察人士視為有助於Quantum Solutions增添資本實力，更進一步鞏固其在全球投資者社群中的聲譽與公信力。三家重量級機構的聯手進駐，無論從資金來源還是象徵意義上，被部分市場人士視為為Quantum Solutions及日本資本市場帶來強力背書。在融資架構上，本輪主要採用可轉換債券以及浮動與固定行權價認股權證，合計發行規模約4,400萬股，近似於現有股份的翻倍。市場分析認為，該融資架構顯示國際投資者對Quantum Solutions長期發展前景的信心，另一方面也為公司未來的戰略轉型提供了充足資本彈藥。市場分析人士指出，經過本次融資強化後，Quantum Solutions的資本結構更趨穩健，不僅具備更強的抗風險能力，亦為投資者帶來估值修復與長期增長的雙重空間。ETH Treasury首例登場，差異化戰略開啟新賽道此次融資落地後，Quantum Solutions將正式啟動其ETH Treasury戰略，以募集資金長期持有以太坊（ETH）。虽在公告内未提及具体运营计划，但市场预测，Quantum Solutions会在合規框架下透過Staking、智能合約與多元流動性策略實現資產增值與風險管理。至此，Quantum Solutions將成為日本首家实质性将ETH納入公司金庫（Treasury）的上市公司，開創本土市場的歷史先例。與眾多選擇比特幣（BTC）作為核心資產的公司不同，Quantum Solutions在戰略層面另闢蹊徑。ETH不僅是一種數位資產，更是整個區塊鏈應用層的基礎設施。其智能合約功能為去中心化金融（DeFi）、NFT、生態協議等提供支撐，使其具備更持續的增值潛力。美國市場的數據顯示，ETH Treasury的估值普遍高於BTC Treasury，市淨率溢價約為6.5倍，顯示投資者對ETH帶來的長期回報有更高期待。換言之，ETH Treasury的差異化邏輯在於「資產+應用」的雙重驅動，有分析認為，Quantum Solutions的策略恰恰抓住了這一先行者優勢。本輪融資完成後，预测其公司預計可逐步累積超過8萬枚ETH，並有望在短期內躋身全球領先的ETH Treasury公司之列。市場觀察認為，結合ARK、SIG與IAM的戰略協同，Quantum Solutions不僅能夠獲得資金與專業知識的輸入，還將在品牌、技術與合規治理方面持續受益。部這一戰略落地對日本市場而言，既是一次新資產類別的制度性突破，也將為本土上市公司在全球區塊鏈版圖中提供一個可供複製的成功範例。對於零售投資者來說，這意味著他們能夠首次通過傳統資本市場的管道，間接參與ETH相關收益，開啟全新的投資故事。日本政策紅利釋放，Quantum Solutions長期主義聚焦股東價值日本市場正在迎來新的轉折點。隨著政府在Web3政策上不斷釋放利好訊號，監管環境日漸清晰與友善，投資者正尋找新的參照標的。相比之下，美國已經出現了BitMine、BTCS等BTC/ETH Treasury公司，市值一路走高，成為資本市場的新焦點；而日本卻一直缺乏同類型的上市公司。分析人士認為，Quantum Solutions的進場，不僅填補了這個空白，更以「日本第一」的身份打開新的篇章。它的出現，等於在市場上立下一個新的定價參考，讓投資者有了一個全新故事可以跟隨，也為資金流入和市場活化創造了條件。值得注意的是，根據公開資訊，Quantum Solutions管理層多年來持續探索新賽道。他們曾經推動AI算力、雲端基礎設施和數位解決方案等業務轉型，每一步都在嘗試新的增長曲線。本輪超260億日圓的融資落地，更是一次關鍵轉折點。市場解讀認為，隨著ARK、SIG和IAM三大國際資本的聯手加持，公司不僅獲得資金支持，更得到國際市場的高度背書，釋放出「聚焦股東價值最大化」的明确信號。分析人士指出，投資者因此認為Quantum Solutions不僅有資本實力，還有國際資源與長期戰略，市場信心自然水漲船高。根據公開資訊，Quantum Solutions管理層一直在探索新賽道。从推動AI算力、雲端基礎設施和AIGC解決方案，每一步都在寻求新的增長曲線。本輪超260億日圓的融資落地，是一次關鍵轉折點。隨著ARK、SIG和IAM三大國際資本的聯手加持，公司不僅獲得了資金支持，更得到國際市場的背書，釋放出「聚焦股東價值最大化」的明确信號。關於 Quantum Solutions根據其官網與公開資訊，Quantum Solutions Co.,Ltd.（東京證券交易所：2338）是一家總部位於日本東京的高成長科技企業，專注於人工智能、大數據分析及區塊鏈相關技術的研發與應用。公司成立於2004年，並於東京證券交易所掛牌上市。更多信息請訪問公司官網：https://www.quantum-s.co.jp/en/corporate前瞻性聲明本新聞稿包含根據公司目前可取得之資訊，以及對未來事件與預期所作的若干假設所形成的前瞻性聲明。此類聲明涉及各種風險與不確定性，包括但不限於政策變動、市場狀況、技術發展及監管因素，皆可能導致實際結果與此類聲明中所表達或暗示的結果出現重大差異。建議現有及潛在投資者審慎評估潛在風險，並避免對本新聞稿中所包含的任何前瞻性聲明寄予過高信賴。此類聲明僅適用於本新聞稿發佈之日，除法律另有規定外，公司並無義務因新資訊、未來事件或其他情況而更新或修正任何前瞻性聲明。如有進一步查詢，請聯絡：香港/國際：Mr. Steven TungEmail: publicrelations@quantum-s.co.jp日本：Ms. Linda PengEmail: publicrelations@quantum-s.co.jp Copyright 2025 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

TOKYO, Sep 29, 2025 - (ACN Newswire via SeaPRwire.com) – Quantum Solutions Co., Ltd. (Tokyo Stock Exchange Code: 2338.T, “Quantum”) announced its strategic financing initiative on September 26 to issue 44 million shares to a blue-chip investor mix of three heavyweight institutions, providing the necessary permanent capital and network access to position Quantum as a potential frontrunner in the world of Ethereum (ETH) listed strategies and a showcase standout in the Tokyo stock market.For Japanese investors, this represents another significant commitment by leading US capital, following Warren Buffett’s investment in Japan’s five major trading companies. For international investors, it signals that Tokyo’s stock market is an increasingly attractive destination for global capital, welcoming new opportunities for “smart money”.Dream Team of Global Capital Aligns for Quantum, International Demand for Japanese Equities Continues to GrowQuantum’s investor line-up is a market stunner in the emerging field of crypto-linked equities. Susquehanna International Group (SIG), investing via CVI Investments, holds the capital firepower to accelerate Quantum’s ETH accumulation and expand its balance sheet for upcoming fundraising rounds. With a portfolio that includes early investments in ByteDance and Strategy Inc. (NASDAQ: MSTR), SIG is a Tokyo Stock Exchange participant, offering the robust capital infrastructure that analysts consider essential for a successful Digital Asset Treasury (DAT).Cathie Wood affirms her position as the world’s leading investor in crypto-linked equities with ARK Invest’s first direct foray into APAC-listed opportunities. In the US market, ARK has a track record for identifying category leaders such as ETH Treasury Bitmine Immersion Technologies (NYSE: BMNR) and cryptocurrency exchange Coinbase (NASDAQ: COIN). By adding Quantum, Wood extends her expertise to the Tokyo market, bringing visibility to Quantum in front of the global investing audience as the region’s most promising ETH Treasury initiative.The third participant is Hong Kong-based Integrated Asset Management (IAM), led by Mr. TC Yam. As the majority shareholder of Forbes Media, IAM’s cross-sector presence in international finance and media resources bolsters Quantum’s capital depth and reputational standing. Like ARK, IAM makes its first public investment in the Tokyo stock market, signaling growing confidence among global institutional investors in Japan's equity market.The fundraise utilizes convertible bonds and both floating and fixed strike price warrants for a total issuance of approximately 44 million shares, nearly doubling the company’s existing share capital. None of the instruments are priced at a discount, a rarity for DAT fundraises, suggesting that the incoming investors are targeting long-term growth prospects. As of market closing on September 26, the nominal value of the financing round comes to over JPY 26 billion (approx. USD 180 million), with the first tranche valued at JPY 22.1 billion (approx. USD 150 million).First ETH Treasury in Japan — A Differentiated Strategy Offering Long-Term Returns on EquityAccording to research reports by leading investment banks, the key determinants of success for listed Digital Asset strategies are robust access to capital and a team with operational blockchain expertise. Through this fundraising initiative, Quantum taps into fresh sources of capital and aligns with investors of strong reputation, prompting market expectations of long-term backing.Quantum CEO Francis B. Zhou is no newcomer to the Digital Asset industry, as one of the first institutional investors and operators in the blockchain space. In 2018, Zhou acquired the world’s second largest ETH mining facility, based in Jokkmokk, Sweden. Zhou maintains investments in early stage blockchain projects alongside film and IP holdings in his venture investment portfolio, and brings a network of experienced blockchain operators, including Head of Crypto Strategy Donny Chi.Proceeds from Quantum’s financing initiative will be used to accumulate ETH. Although BTC has demonstrated adoption as a store-of-value, ETH is the foundational asset for blockchain applications, enabling companies like Quantum to explore attractive yield-generating opportunities to drive a blend of organic and inorganic growth for the company’s core treasury and balance sheet.The appeal of yield-bearing strategies is supported by data from the US market, which indicates that listed ETH Treasuries trade at a price-to-book multiple of 7.72x, more than 3 times higher than that of listed BTC Treasuries. More remarkably, the price-to-book of ETH Treasuries is trending upwards, increasing by over 20% within the trading month of September, demonstrating that the market expectations continue to strengthen for listed ETH Treasuries as it relates to long-term returns on equity.Zhou and the Quantum Solutions team have a history of exploring growth frontiers, consequently developing industry traction in AI computing, GPU hosting, and IP gaming. This positions the company to pursue unique opportunities beyond overcrowded sectors in Real World Asset (RWA) space to potentially generate more attractive returns.With the fundraise, Quantum’s notional price-to-book multiple is estimated to be less than 30% of the market median. Assuming that the company can reach its fair value, the structure of the fundraise allows the company to rapidly accelerate its capital accumulation to reach the target of 100,000 ETH within the near term, positioning Quantum among the leading ETH Treasury companies globally.Growth Driven Policies in Japan Encourage Prospects for Long-Term Shareholder ValueConsistent government support for the blockchain industry and increasing clarity in regulations are ushering in a more investor-friendly market for Digital Assets in Japan. Whereas the US market already has ETH Treasury companies such as Bitmine (NASDAQ: BMNR) and SharpLink Gaming (NASDAQ: SBET) achieving significant market cap growth as capital market highlights, Japan lacks a similar listed benchmark. Quantum Solutions’ entry fills this gap, opening a new chapter as "Japan’s first”, and creating conditions for capital inflow and renewed market participation.This financing round, nominally valued at approximately USD 180 million, is a landmark in both the Japanese stock market as well as the crypto-linked equities space. Through the combined endorsement of SIG, ARK, and IAM, Quantum not only secures funding but also international validation under a capital structure optimized to maximize long-term shareholder value. High-profile deals of this caliber further Tokyo as an emerging destination for savvy investors. Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

TAIPEI, TAIWAN, 2025年9月29日 - (亞太商訊 via SeaPRwire.com) - 新加坡 —— 新交所凱利板上市公司 Mooreast Holdings Ltd.（以下簡稱「Mooreast」或「集團」）今日表示，已與中國交通建設股份有限公司（「中交股份」）旗下子公司簽署《戰略合作協議》（「SCA」）。中交股份是中國國有的全球基礎設施開發領導企業。根據該協議，Mooreast 與中交機電工程有限公司（「中交機電」）計劃合作，在中國及全球其他地區共同開發浮式海上再生能源及相關近海與海洋工程專案的商機。該戰略合作將充分發揮中交機電在中國境內的規模化營運、專業技術、資源、聲譽與網絡優勢，同時結合Mooreast 在綠色低碳發展與浮式再生能源領域（包括海上風電）的技術能力、成功經驗與國際網絡。雙方亦將探索建立海上風電相關產業供應鏈的合作機會，提供涵蓋工程、採購、施工與安裝（EPCI）的綜合解決方案。Mooreast 與中交機電計劃推進涉及浮式風能及其他近海與海洋工程專案的合作，範圍包括工程設計、生產、分裝、運輸及／或系泊與索具系統、風力發電機、浮式平台及相關零部件或設備的安裝等。儘管這些產品與解決方案的主要市場在中國本土，但鑑於亞洲地區技術水平日益提升且生產成本持續下降，雙方亦看好海外市場的成長機遇。作為近海與海洋領域系泊與索具系統的專業公司，Mooreast 是亞洲唯一一家超高功率錨具設計與製造商。隨著全球浮式風電專案的商業化步伐加快，公司正積極擴展其在歐洲和東北亞的市場布局。Mooreast 執行董事兼副主席沈君南先生表示：「我們非常高興並榮幸能與中交機電這樣享有盛譽的企業建立合作。與陸上風電相比，中國的浮式海上風電產業仍有巨大潛力尚待開發。我們期待在不久的將來深化合作，把握國內外市場機遇。」本新聞稿已由公司贊助商大華繼顯私人有限公司（「贊助商」）審閱。本新聞稿尚未經新加坡交易所有限公司（「SGX-ST」）檢驗或批准，SGX-ST 對本新聞稿的內容不承擔任何責任，包括其中所載之陳述、意見或報告的正確性。贊助商聯絡人為大華繼顯私人有限公司高級副總裁 Lance Tan先生，地址：83 Clemenceau Avenue, #10-01 UE Square, Singapore 239920，電話：(65) 6590 6881。本新聞稿由 WeR1 Consultants Pte Ltd 代表 Mooreast Holdings Ltd. 發佈。關於 Mooreast Holdings Ltd.作為全面系泊解決方案的領導者，Mooreast 為近海石油與天然氣、航運及海上再生能源產業提供系泊系統的設計、工程、製造、供應與物流、安裝及調試等服務。憑藉近三十年的經驗，Mooreast 正將其在系泊解決方案領域的實績與專業能力應用於浮式再生能源專案，特別是浮式海上風電。公司已成功參與日本與歐洲的浮式海上風力發電機開發與原型專案。更多資訊，請瀏覽 https://mooreast.com/媒體與投資者聯絡方式WeR1 Consultants Pte LtdIsaac Tang, mooreast@wer1.net（手機：+65 9748 0688） Copyright 2025 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, Sept 29, 2025 - (ACN Newswire via SeaPRwire.com) - Tianli International Holdings Limited (“Tianli International”) and Shenzhen Yidatong Group recently held a formal signing ceremony in Hong Kong to launch their strategic partnership. The agreement, signed at 3:00 PM on September 25th, marks the official start of a high-end international school project in the heart of Laos’s National Administrative Center.This collaboration represents far more than a commercial alliance. It is a key milestone in Tianli International’s dual strategic priorities—“Education AI” and “China International Education Going Global”—and a concrete step in response to China’s Belt and Road Education Initiative and the national blueprint China Education Modernization 2035, which calls for “a new era of educational openness.”Under the agreement, the partners will jointly develop a world-class international education complex featuring two flagship schools:Premier British Boarding School, offering a complete UK curriculum and authentic boarding traditions to nurture the next generation of global leaders from Laos and neighboring countries.Lida Chinese International School, centered on China’s national curriculum, this school will provide both general and academic Chinese tracks, establish a direct pathway to China’s top universities, and promote two-way student exchange programs.The signing ceremony drew congratulations from the China Association for Non-Government Education, which praised the project as a pioneering example of Chinese private education expanding abroad. Guests and witnesses attended from China, Laos, France, Malaysia, Gambia, and other countries.Dr. Luo Shi, Chairman and President of Tianli International, stated that the partnership is both a pivotal milestone in the group’s global strategy and a major advance in its “Education AI + China International Education Going Global” initiative. Looking ahead, the two partners plan to explore innovations in smart-campus infrastructure and AI-driven teaching, delivering high-quality, diversified education options to Southeast Asia and the wider world.Media ContactCompany: Tianli Education (HK ) LimitedContact Person: Dr. Brown FengZhaoEmail: zhaofeng@tianlieducation.com Website: https://www.tianlieducation.com/en/about/index.html Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港，2025年9月29日 - (亞太商訊 via SeaPRwire.com) - 港股礦產資源板塊近期表現強勁，除了受惠於金價、銅價因減息週期、印尼大型銅礦停產而創出新高帶動外，還有備受市場矚目的紫金礦業（02899.HK）旗下紫金黃金國際分拆上市的熾熱招股反應。市傳紫金黃金國際公開發售股份錄得孖展超購逾190倍，凍資近4800億港元。此次全球發售還吸引了包括新加坡政府投資公司（GIC）、高瓴資本在內的超豪華基石投資者陣容。摩根士丹利、瑞銀等一眾國際投行因應目前市場情況已分別再度調升金價及銅價預測，並對未來的黃金、銅的價格維持上行走勢表示樂觀。從現貨黃金市場表現來看，9月26日亞市早盤時段現貨黃金於3739.08美元/盎司附近高位震盪，一度達3757.14美元/盎司，創下歷史新高點。而上海期貨交易所(SHFE)最活躍的銅期貨合約同日亦上漲0.32%，至每噸82420元人民幣(約11678.3美元)。紫金黃金國際的IPO熱潮與黃金、銅等價格的持續新高，為港股市場上的礦業股表現提供了絕佳的時間窗口。在聚焦板塊機會、挖掘潛力標的過程中，一間尚未被充分關注的企業——比優集團（09893.HK），其潛藏的「含『金』量」正值得深挖。作為港股市場稀缺的「礦山+民爆」概念股，比優集團通過差異化經營優勢，正逐步進入投資者的視野。其中，集團核心資產——安徽金鼎礦山，依託成熟的提金工藝和穩定的產能，正在成為公司業績的重要支撐。2025全年財報數據顯示，安徽金鼎共生產含金泥約850公斤，含金量約20%，折合純金產量約170公斤。銅金共生資源亦十分亮眼，2024全年開採77.9萬噸銅金礦，平均金品位0.66g/t，銅金精礦加工產出1.91萬噸，平均金品位顯著提升至16.75g/t，為黃金產能的持續釋放奠定了堅實基礎。隨著金、銅板塊關注度的不斷提升，兼具獨特商業模式與清晰成長路徑的比優集團，正迎來價值重估的關鍵窗口。板塊東風已至，價值重估正當時作為港股市場中唯一的民用爆破上市公司，公司已構建起"「民爆+礦山」垂直一體化業務格局。2025財年，公司實現營業額16.96億元人民幣(下同)，同比增長24.09%；股東應佔溢利1.64億元，同比增長25.20%。在礦業板塊熱度提升的背景下，此類業務獨特、賽道專精的企業更易獲得流動性溢價與估值重塑的機會。值得注意的是，比優集團於2025年2月18日成功由港交所創業板轉至主板，成為港交所「簡化轉板機制」實施後的首個案例。這一轉變不僅是市場認同度提升的變更，更是公司治理結構、資訊披露透明度與投資者基礎的一次全面升級。隨著國際機構投資者的基礎擴大，比優集團自加入主板後，股價取得良好的漲幅。國際股票交易及投資信息平台Simply Wall Street 於9月15日發表的《Undervalued Small Caps With Insider Buying In Global For September 2025》文章將公司評選為全球十大被低估的中小盤股，較合理估值存在約42%的折讓空間。比優集團引起國際投資機構的注意，除業績佳、增長潛力大以外，公司的發展策略緊密契合國家政策與區域經濟脈絡亦是投資價值重點所在。在國內，安徽金鼎項目的產能持續釋放，並於2023年入選首批安徽省級綠色礦山企業。同時，西藏天仁項目已於2025年1月獲西藏自治區發改委核准，預計2026年底投產；海外業務方面，公司自2017年佈局塔吉克斯坦市場，已成為當地最大民爆生產商。這種深耕本土+出海的雙線佈局，合理分散了區域風險。安徽金鼎礦——穩健的"產能壓艙石"值得留意的是，根據年報披露，安徽金鼎項目持有黃屯硫鐵礦與銅金多金屬礦的採礦權，採礦許可證於2016年3月頒發，2043年8月才到期，並可依規延期。2025財年(截至3月31日)資料顯示，安徽金鼎項目經營狀況穩健，盈利水準持續提升，收入已佔總收入近半，成為集團穩定發展的堅實支點。據瞭解，安徽金鼎的15萬噸/年硫精礦焙砂提金選礦技術改造工程項目經一年多的試運行後，相關產能進一步釋放。2024財年該項目已實現黃金回收約170公斤；截至2025年1–8月，累計黃金產量已達150公斤，產能持續穩定釋放。安徽金鼎憑藉穩定的黃金產能、成熟的提金工藝及充足的資源儲備，將繼續發揮"壓艙石"的作用，為集團業績增長提供堅實保障。2025財年，安徽金鼎項目共生產礦石96.09萬噸，其中銅金礦77.91萬噸，平均品位金0.66 g/t、銅0.39%；硫鐵礦8.11萬噸，平均品位硫19.57%、金0.29 g/t；磁鐵礦10.08萬噸，平均品位鐵20.98%、金0.34 g/t。展現出強勁的產能兌現能力。根據John Boyd Mining Consulting(Beijing)Company Limited（"博多"）審核資料，截至2025年3月31日，安徽金鼎西區金銅礦探明資源量900萬噸、推斷資源量220萬噸。礦石儲量方面，西區金銅礦概略儲量772萬噸，東區硫鐵礦概略儲量657萬噸。充裕的資源儲備為產能的長期穩定釋放提供了堅實保障。排產計劃顯示，2026-2035年間，安徽金鼎年礦石產量將基本維持在100萬噸水準，其中銅金礦石佔比約82%，黃金品位維持在0.67-1.04 g/t區間，保證了黃金產出的連續性與穩定性。與此同時，還要留意其銅、硫鐵等的輸出，尤其在國際銅價保持在高位運行的預期下，安徽金鼎的利潤有望持續提升。來源：公司財報從業績貢獻來看，安徽金鼎礦業項目已然成為比優集團利潤增長的核心引擎。過去三年，收入實現跨越式增長，從2億元快速攀升至8.33億元，年複合增長率超過60%，收入佔比已與集團傳統民爆業務相當。同時，安徽金鼎"採礦-選礦-提金"的產業鏈與集團民爆業務形成協同效應——民爆產品為採礦環節提供爆破支援，有效降低運營成本，進一步強化盈利韌性，持續為集團貢獻穩定收益。在國際貴金屬價格狂飆，紫金黃金國際赴港上市所引領的板塊"東風"之下，比優集團已具備價值重估的多重催化劑。當下，市場資金開始系統性資金配置於估值落後的黃金資源與工業金屬股，這類治理完善、業務可見性強、且具備明確成長路徑的中小型企業，有望成為下一階段資金挖掘的重點目標。 Copyright 2025 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港，2025年9月28日 - (亞太商訊 via SeaPRwire.com) - 9月26日，「聚力五載 共創未來」上實資本2025年度投資人大會在上海、香港兩地同步舉行。值此上實資本成立五周年之際，各界嘉賓齊聚一堂，既回顧五年來深耕投資的堅實歷程，更聚焦「滬港協同發展」的新機遇 - 發揮香港國際金融中心優勢，未來將進一步深化滬港協同，按照上實集團「立足香港、依託上海，服務國家戰略、走國際化道路」的戰略定位，共探跨境資本賦能生命健康、環境健康產業的新路徑。上實集團董事長冷偉青在致辭中表示，面對科技變革浪潮，上實集團立足香港、依託上海、面向全球，主動擁抱創新，在變革中搶抓機遇，聚焦生命健康、環境健康兩大主賽道，推動「科技+金融+產業」 的協同發展。上實資本作為集團基金管理和戰略直投平台，過去五年，成功打造「生物醫藥」基金矩陣，支持香港本地生物科技企業科研成果轉化，推動全球優質技術與滬港資本、產業資源融合。未來，上實資本將發揮香港平台連結全球資源，在科技創新領域進一步深化滬港協同，以基金為紐帶，助力香港在生命健康、環境健康領域的創新成果落地轉化，完善跨境投資鏈條。圖注：上實集團董事長冷偉青致辭上實集團首席金融與投資官、上實資本總裁谷峰在主旨演講中，回顧了上實資本五年間 「立足上海，聯動香港，輻射全球」的發展脈絡。他強調，面對全球產業變革，上實資本將以 「滬港聯動」 為核心抓手，通過新基金佈局與現有基金擴募，持續強化生命健康、環境健康的投資能力。同時，港股基石投資基金的成立，也精準補齊了滬港兩地戰略產業領域投資的最後一環。上實資本未來的部署將以國家戰略為導向、以集團戰略為支撐，強化雙平台協同，完善跨境基金矩陣，深化與香港本地資源的合作，助力香港打造國際綠色金融中心與生物醫藥創新中心，推動資本與產業深度的融合，踐行集團「服務國家戰略、走國際化道路」的核心定位。圖注：上實集團首席金融與投資官、上實資本總裁谷峰發表主旨演講本次大會的重要亮點之一，是 "上實資本科技基金（STC）" 品牌的正式發佈。作為上實資本聚焦綠色健康賽道的核心載體，STC 將進一步拓展環保能源、具身智能、低空經濟等細分產業賽道。依託香港綠色金融的優勢，為科創企業提供「資本 + 生態」的雙重賦能，推動滬港綠色科技項目跨境聯動，助力香港打造國際綠色科技投資樞紐。圖注：上實資本科技基金（STC）品牌發佈為深化滬港兩地戰略產業協同，上實集團攜手國泰海通在大會上簽署"滬港戰略產業基石投資基金"合作協議。該基金作為上實資本佈局滬港跨境投資的關鍵舉措，將重點聚焦「上海戰略新興產業赴港上市前最後一公里的融資」——填補滬港跨境投資鏈條的空白。基金首期規模與香港合作方參與細節將後續公佈，預計將成為香港資本市場服務內地戰略產業企業赴港上市的重要橋樑。圖注：滬港戰略產業基石投資基金簽約儀式大會同期簽署四項重磅合作協議，其中兩項與香港產業發展高度相關：1、上實集團 - Azzurra Capital 合資合作：雙方將共同在港設立基金投資平台，聚焦全球綠色科技、環保能源項目，推動全球環境健康領域優質技術與中國產業資源、市場資源，香港資源深度融合。圖注：上實集團-Azzurra Capital合資合作簽約儀式2、香港生物科技基金擴募：作為上實資本深耕香港生物醫藥領域的核心基金，本次擴募將進一步加大對香港本地生物科技企業的投資力度，同時聯動香港科技大學、香港生物醫藥創新協會等機構，支持科研成果轉化，重點投向基因治療、創新藥研發等細分領域，助力香港建設國際生物醫藥創新中心。圖注：香港生物科技基金擴募及戰略合作簽約儀式此外，上實環境科技基金、上海生物醫藥基金二期戰略合作協議的簽約，也進一步完善了上實資本「人民幣基金 + 跨境基金」 的多層次佈局，兩隻基金將與香港生物科技基金、滬港戰略產業基石投資基金形成協同，為香港資本市場注入更多優質內地產業標的，持續深化滬港兩地資本與產業的聯動。圖注：上實環境科技基金合作簽約儀式圖注：上海生物醫藥基金戰略合作暨二期啟動儀式大會兩場圓桌論壇中，「雙城慧話 —— 滬港聯動創新發展」 專場尤為引發香港業界關注。論壇由上實資本旗下香港生物科技基金總裁梁衛彬主持，香港生物醫藥創新協會會長盧毓琳、香港科技大學投資基金負責人姚博文、香港尚至醫療集團資深合夥人張仁宇等嘉賓，圍繞「滬港聯動新發展」展開深入討論。嘉賓普遍認為，上實資本此次新基金佈局與香港生物科技基金擴募，將為香港產業注入新動能，期待未來與上實資本在科研轉化、基金合作、人才交流等方面深化聯動。圖注：雙城慧話 —— 滬港聯動創新發展圓桌論壇另一場 「併購論道」 圓桌論壇則聚焦產業整合與價值創造，高盛（中國）、華平投資等機構代表提及，香港作為國際金融中心，併購項目在融資、退出方面可充分借力香港資本市場，進一步釋放內地與香港的協同價值。本次大會不僅是上實資本五周年的總結，更是滬港跨境投資生態升級的新起點。未來，上實資本將以生命健康、環境健康為主賽道，持續強化香港平台作用，為香港投資人、企業、科研機構搭建更高效的跨境合作橋樑，共同助力香港打造國際綠色金融中心與生物醫藥創新中心，實現 「聚力五載、共創滬港產業新未來」 的目標。 Copyright 2025 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港，2025年9月28日 - (亞太商訊 via SeaPRwire.com) - 9月26日下午，由全球商報聯盟、香港商報聯合主辦的2025全球商報經濟論壇暨「金鯤鵬」中國財經價值榜頒獎盛典，在香港喜來登酒店宴會廳隆重舉行。會上公佈了2025「金鯤鵬」中國財經價值榜獲獎公司及企業家名單，中國平安財產保險股份有限公司（以下簡稱"平安產險"或"公司"）在一眾參選公司中脫穎而出，最終斬獲"最佳公司治理金融機構"獎項。全球商報經濟論壇至今已舉辦七屆。本屆2025全球商報經濟論壇暨「金鯤鵬」中國財經價值榜系列活動以"在世界變局中擁抱新機遇"為主題，旨在聚焦中國經濟發展新動能，展現具有代表性的標杆企業，並結合香港的獨特優勢，為中國企業尋找全球發展新機遇。此次活動邀請來自中國內地及香港特區政府官員、券商高管、投資機構、內地及香港上市公司、創投機構負責人等，超300位與會嘉賓出席。香港商報常務副社長、執行總編輯藍岸、財經事務及庫務局副局長陳浩濂、國務院國資委新聞中心副主任張義豪、中信證券國際有限公司聯席首席執行官許建強、創新科技及工業局副局長張曼莉等多位領導參會並致辭。"金鯤鵬"中國財經價值榜旨在遴選引領行業發展變革，業界榜樣標杆的傑出企業與人物，以"創新性、公司治理、價值力、戰略前瞻性、成長性、社會責任與可持續發展"六大核心維度為評判標準。在組委會和主辦機構推薦的基礎上，綜合入圍公司及專業諮詢機構提供的客觀指標和主觀指標兩大數據指標計分，經過報名初審、數據採集審定、專家顧問團評審和組委會定榜等環節，最終產生中國財經價值榜企業獲獎名單。"最佳公司治理金融機構"評選更是基於多項指標綜合評估，包括治理架構、透明度、風險管理、股東權益、社會責任等五大核心維度。平安產險在各方面均表現出色，最終斬獲這一殊榮。榮膺這一重量級獎項，充分體現了公司治理體系建設成效與行業標杆價值。中國平安財產保險股份有限公司於1988年誕生於深圳蛇口，是中國平安保險（集團）股份有限公司（以下簡稱"平安集團"）實現綜合金融多元化發展的起點與核心業務板塊。近年來，平安產險緊跟"五篇大文章"、"國十條"等國家戰略部署，緊抓行業發展與技術變革機遇，堅定推進數位化轉型，以科技賦能業務發展，全面提升核心競爭力。2024年，平安產險實現原保險保費收入3218.2億元，同比增長6.5%。作為中國第二大財產保險公司，平安產險開發、經營的主險已超過1000種，經營業務範圍涵蓋車險、企財險、農險、工程險、貨運險、責任險、保證險、信用險、家財險、意外及健康險等一切法定財產保險業務及國際再保險業務，服務網絡覆蓋全國，累計為超過2億個人客戶及數百萬家機構客戶提供全方位、多層次的風險保障與保險服務。持續完善公司治理體系，提升治理效能，推動高質量發展平安產險始終堅持以"金融為民"的初心和"治理先行、戰略引領、責任擔當"的發展理念，持續完善公司治理體系，提升治理效能，推動高質量發展。在公司治理架構方面，平安產險構建了權責清晰、運行高效的"四會一層"治理機制，確保黨委政治引領、董事會專業決策、監事會獨立監督、管理層高效執行的有機統一，治理體系持續健全。平安產險承接平安集團上市公司治理規範，構建了職責清晰、運行高效、協調制衡的現代公司治理架構，確保董事會專業性與獨立性、專業委員會設置合理、高管激勵機制與公司長期戰略高度匹配。在高管激勵機制方面，堅持戰略導向與風險共擔原則，建立"價值共創、成果共用"的治理文化，通過績效掛鉤、中長期激勵相結合，推動管理層行為與公司長期戰略目標高度契合。在風險管理方面，平安產險建立了覆蓋全面、機制健全、執行有力的全面風險管理體系，強化風險識別、評估與應對能力，有效應對複雜多變的市場環境，保障公司穩健運營。在股東權益保護方面，平安產險堅持依法合規、公平公正原則，通過穩定分紅政策、便利投票機制（包括累積投票制度）及異議股東回購安排，切實保障全體股東，特別是中小股東的合法權益。在社會責任方面，公司將ESG理念深度融入公司治理與日常運營，積極踐行綠色金融、普惠金融、風險減量服務與公益行動，持續提升社會影響力與品牌公信力。憑藉在公司治理體系建設、風險合規管理、消費者權益保護、股東回報機制及社會責任履行等方面的持續深耕與創新實踐，平安產險有信心、有能力持續引領行業治理標杆，助力國家金融治理體系和治理能力現代化建設。 Copyright 2025 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港，2025年9月28日 - (亞太商訊 via SeaPRwire.com) - 9月26日下午，由香港商報、全球商報聯盟聯合主辦的2025全球商報經濟論壇暨「金鯤鵬」中國財經價值榜頒獎典禮在香港成功舉辦。中集安瑞科（3899.HK）在一眾參選公司中脫穎而出斬獲"最佳上市公司"獎項；公司執行董事、總裁楊曉虎榮獲"最具影響力上市公司領軍企業家"獎項。 此次活動邀請來自中國內地及香港特區政府官員、券商高管、投資機構、內地及香港上市公司、創投機構負責人等。香港商報常務副社長、執行總編輯藍岸、香港財經事務及庫務局副局長陳浩濂、國務院國資委新聞中心副主任張義豪等多位領導參會並致辭。楊曉虎參與了現場論壇圓桌演講環節，與天齊鋰業高級副總裁張文宇、萬咖壹聯董事長高弟男共同探討 "十五五"政策新機遇。楊曉虎表示，政策支持給清潔能源行業帶來的增長空間值得期待。他表示："中集安瑞科將重點發力培育清潔能源行業的"新質生產力"，通過"線上互聯"及"線下智能"兩張網推動行業數字化升級；同時他表示，在"十五五"期間人形機器人、AI這些創新產業蓬勃發展的背後，清潔能源無疑會作為"綠色算力能源"為產業躍升提供堅實支持。" 楊曉虎（右二）出席圓桌演講談及公司在港佈局思路，楊曉虎稱，中集安瑞科作為在港股上市的清潔能源企業，未來會更深度地參與到香港綠色金融的發展進程中，並通過綠色甲醇船舶燃料的佈局以及氫能技術創新協助香港綠色產業在全球獲得更多"綠色溢價"。此次獎項設置旨在遴選引領行業發展變革，業界榜樣標杆的傑出企業與人物，以"創新性、公司治理、價值力、戰略前瞻性、成長性、社會責任與可持續發展"六大核心維度為評判標準；中集安瑞科獲得「最佳上市公司」獎項，公司領導獲得「最具影響力上市公司領軍企業家」獎項，既是主辦方對中集安瑞科過往經營實力與戰略佈局的肯定，也充分體現公司實力以及資本市場的高度認可。未來，中集安瑞科將繼續依託多元業務協同優勢，深耕綠色能源賽道、拓展全球化市場，在清潔能源領域不斷推動技術創新與模式創新，為行業發展注入更多新動能。 Copyright 2025 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

SHENZHEN, Sept 28, 2025 - (ACN Newswire via SeaPRwire.com) - China Medical System Holdings Limited (“CMS”) is pleased to announce that its subsidiaries, Dermavon Holdings Limited (“Dermavon”, an innovative pharmaceutical company specialized in skin health which is applying for a separate listing on the Main Board of The Stock Exchange of Hong Kong Limited, please refer to the announcement published by CMS on 22 April 2025 for details) together with its subsidiaries, obtained positive results from the phase 3 clinical trial (the “Trial”) of ruxolitinib cream (the “Product”) in patients with mild to moderate atopic dermatitis (AD) in China.The Trial is a randomized, double-blind, placebo-controlled, multi-centre clinical trial, with 192 patients enrolled in total, aiming to evaluate the safety and efficacy of the Product in patients with mild to moderate AD. The leading institution is Shanghai Dermatology Hospital, and the principal investigator is Professor Shi Yuling.The phase 3 clinical trial of ruxolitinib cream in patients with mild to moderate AD in China met its primary endpoint, demonstrating that a significantly higher proportion of patients treated with ruxolitinib cream achieved IGA (Investigator's Global Assessment) of 0 or 1 with at least two grades of reduction from baseline at week 8, compared with placebo (63.0% vs 9.2%, P

深圳，2025年9月28日 - (亞太商訊 via SeaPRwire.com) - 康哲藥業控股有限公司（「康哲藥業」）欣然宣佈，旗下德鎂醫藥有限公司（「德鎂醫藥」，專業聚焦皮膚健康的創新型醫藥企業，正申請於香港聯合交易所有限公司主板獨立上市，詳見康哲藥業日期為2025年4月22日發佈的公告）連同其附屬公司取得磷酸蘆可替尼乳膏（「蘆可替尼乳膏」或「產品」）輕中度特應性皮炎（AD）的中國三期藥物臨床研究（「試驗」）積極結果。該試驗是一項在中國人群開展的隨機、雙盲、安慰劑對照、多中心的臨床研究，共入組192例患者，旨在評估產品治療輕中度AD的安全性和有效性。該研究組長單位為上海市皮膚病醫院，主要研究者為史玉玲教授。產品用於輕中度特應性皮炎的中國三期臨床研究成功達到主要終點，即使用蘆可替尼乳膏治療8周，達到研究者整體評估（IGA）評分為0或1分，且較基線改善≥2分的受試者比例，顯著高於安慰劑（63.0% vs 9.2%，P

SINGAPORE, Sept 27, 2025 - (ACN Newswire via SeaPRwire.com) - Academic Labs, the team building the first Universal Database of Knowledge for decentralized autonomous learning, has secured a strategic investment from Evergreen Profits.The announcement follows the recent listing of Academic Labs’ native token, $AAX, on Biconomy—an inflection point that broadens liquidity and participation while aligning incentives across developers, contributors, and institutional partners.What is Academic Labs?Academic Labs is architecting a transparent, interoperable knowledge layer where AI agents can autonomously learn, verify, and teach skills.By combining gamified learning, DAO-based governance, and data interoperability, the project aims to create a consensus-driven intelligence substrate that is open, verifiable, and portable across ecosystems.Since launching its MVP in January 2024, Academic Labs has seen rapid adoption—200,000 videos and challenges completed in the first month—alongside notable community and institutional engagement through hackathons and courses at QS Top 50 universities. Its Project Education initiative now supports over 20 ecosystems and reaches more than two million people worldwide.On the market front, the project recorded over $6M in first-day trading volume on Gate and completed BGA’s light incubation program under Bybit.Strategic Timing: Post-$AAX Biconomy ListingThe timing of Evergreen Profits’ investment is strategically significant. With $AAX newly listed on Biconomy, Academic Labs gains distribution that can anchor real utility: staking for curation and quality assurance, contributor rewards for challenge creation and validation, and governance participation in how the Universal Knowledge Graph is expanded and audited.Investor Fit and ComplementarityEvergreen Profits’ thesis-driven approach—built on adapting to cyclical market regimes—complements this next phase by emphasizing operational discipline, risk-aware growth, and standards that support long-term composability. Their portfolio experience across AI, data, and Web3 is expected to inform Academic Labs’ interoperability roadmap and agent-facing APIs.The investment will be directed toward three priorities.First, deepening the core protocol: advancing the Universal Knowledge Graph, extending agent APIs, and implementing on-chain verifiable credentials for proof-of-skill.Second, strengthening governance and incentives: refining DAO mechanisms for reputation, staking, and curation to ensure that knowledge ingestion and validation are transparent, auditable, and resistant to manipulation.Third, accelerating ecosystem growth: expanding university partnerships, developer programs, and cross-chain integrations so that content supply, challenge design, and agent training data scale in tandem with quality controls.What distinguishes this partnership is its emphasis on verifiability and portability. In an environment increasingly shaped by agentic AI, the bottleneck is not model capacity but trustworthy, structured knowledge and the signals that govern its use.By coupling $AAX’s broadened liquidity with Evergreen Profits’ cycle-aware capital and operational guidance, Academic Labs aims to turn raw educational content into an on-chain, consensus-curated knowledge asset that AI agents can query, learn from, and contribute back to—while users retain visibility into provenance and incentives.About Academic LabsAcademic Labs is building the 1st Universal Database of Knowledge that empowers decentralized autonomous learning for AI agents that assist users in acquiring skills and knowledge, fostering consensus-based intelligence for all of human society. Through gamification, DAOs, and data interoperability, we offer a limitless, transparent, and personalized channel for sharing and learning various skills.Trade AAX: https://www.biconomy.com/exchange/AAX_USDTSocial LinksX: https://x.com/Acad_LabsTelegram Group: https://t.me/academic_labsLinktree: https://linktr.ee/academic_labsDiscord: https://discord.gg/academic-labsMedia ContactBrand: Academic LabsContact: Media teamWebsite: https://acad.live Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

倫敦, 2025年9月27日 - (亞太商訊 via SeaPRwire.com) - 一項針對英國 31 種乾犬糧的全生命周期評估顯示，植物性飲食在所有主要環境指標上皆穩定優於肉類為基礎的替代方案。這項研究由諾丁漢大學的獸醫研究人員 Rebecca Brociek 與 David Gardner 教授主導，並發表於《永續食物系統前沿》（Frontiers in Sustainable Food Systems），凸顯了寵物飼主與寵糧產業在減少生態「爪印」方面的重要契機。關鍵成果溫室氣體排放：植物性犬糧每 1,000 大卡僅產生 2.82 公斤二氧化碳當量，相比之下，牛肉配方高達 31.47 公斤，超過十倍之多。土地使用：植物性飲食每 1,000 大卡僅需 2.73 平方公尺土地，而牛肉製品則高達 102.15 平方公尺。用水量：植物性選項每 1,000 大卡耗用 249 公升淡水，遠低於牛肉（575 公升）或羊肉（684 公升）。營養與酸化污染：牛肉飲食所產生的酸化與優養化排放量，分別比植物性飲食高出 14 至 16 倍。中間方案：以家禽為基礎或半合成獸醫配方的影響雖低於紅肉，但仍遠高於植物性食品。在一般 9 年的壽命中，若一隻 20 公斤的拉布拉多犬完全食用植物性乾糧，將僅需 8,964 平方公尺土地，並產生相當於 2.8 趟倫敦—紐約往返航班的溫室氣體排放。若同樣的狗以牛肉為基礎的犬糧餵養，則需要 334,851 平方公尺土地，並排放相當於 31.3 趟倫敦—紐約往返航班的溫室氣體。為何重要隨著全球飼養寵物的人數不斷上升，寵物食品需求日益增加，動物性成分所帶來的環境衝擊已無法再被忽視。研究人員總結指出，在寵糧中增加植物性成分，是一種務實且可擴展的方法，可有效減少土地使用、排放、營養污染與水資源壓力，而不會影響熱量供應。研究並指出：「讓狗狗食用植物性飲食，將顯著提升家庭的環境永續性」，以及「低環境衝擊的寵糧成分，將是降低[寵糧]產業生態『爪印』的關鍵。」雖然有人認為使用副產品如「肉粉」會更具永續性，但研究發現，這些往往位列影響最大的成分之一，並未能真正縮小差距。更廣泛的脈絡這項研究支持了先前的相關研究。2023 年，獸醫學教授 Andrew Knight 曾證實，若全球的寵物犬全面改採營養完整的純素飲食，所節省的溫室氣體排放量將相當於 英國年排放量的 1.5 倍，同時可提供足以餵養 4.5 億人（約等於歐盟人口）的食物能量。到 2025 年底，已有至少11 篇經同儕審查的研究顯示，狗狗採用植物性飲食後健康狀況皆有正面結果。Knight 教授進一步說明：「較高比例的植物性成分，或營養完整的植物性飲食，能大幅減少伴侶動物的生態足跡。隨著意識逐漸提升，這類飲食可能會從小眾轉為主流——使我們對寵物的關愛，與對地球的責任相互契合。」聯絡資訊Andrew KnightVeterinary Professor of Animal Welfareandrew.knight@murdoch.edu.au+44 7577 899 61來源: Sustainable Pet Food Foundation Copyright 2025 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, Sep 26, 2025 - (ACN Newswire via SeaPRwire.com) – The recent Presidential Proclamation from the White House, instituting a substantial one-time fee of US$100,000 for new H-1B visa holders entering the United States, has created uncertainty for employers and professionals navigating the global talent market. While the policy aims to incentivize domestic hiring, it also accelerates the need for cost-effective and compliant international workforce solutions. Galaxy Payroll Group Limited (Nasdaq: GLXG) ("Galaxy" or the "Company"), a leading global payroll provider in the Asia-Pacific region, is committed to helping companies navigate these changes with its specialized suite of services.Rising Demand for EOR and International Payroll ServicesThe new regulation significantly increases the cost and complexity of relocating international talent to the U.S. In response, multinational corporations, particularly small and medium-sized enterprises (SMEs) and startups with limited budgets, are expected to seek alternative deployment models to maintain access to a global talent pool without incurring prohibitive expenses.To circumvent the hefty fee and intricate visa processes, businesses are increasingly likely to adopt remote hiring models, engaging talent directly in their home countries. This shift drives demand for Employer of Record (EOR) and international payroll outsourcing services, which allow companies to legally employ staff abroad without establishing a local entity."This policy has created challenges for employers and workers alike," said Mr. Wai Hong Lao, Chief Executive Officer of the Company. "Our expertise in payroll outsourcing and employment services across Hong Kong, Taiwan, Macau, and Mainland China in the Asia-Pacific region positions us to help companies navigate these changes and ensure full compliance with local regulations."Enhanced Capabilities with Stablecoin SettlementsGalaxy Payroll Group has further enhanced its service offerings by supporting payroll settlements in stablecoins. This innovative payment method provides companies with a more efficient, transparent, and cost-effective solution for managing cross-border payroll, especially for remote employees. By leveraging stablecoins, Galaxy Payroll Group helps companies reduce the risks associated with currency fluctuations and streamline their international payroll processes.Accelerated Adoption of Integrated Payroll TechnologyAs companies build more distributed teams, the need for streamlined, transparent, and efficient cross-border payroll management becomes critical. Galaxy Payroll Group’s focused technological solutions are designed to simplify multi-jurisdiction payroll processing, tax calculations, and compliance reporting within its operational regions. This capability aligns perfectly with the growing need to manage dispersed teams effectively, making integrated payroll technology a necessity rather than a luxury.Broad Market Opportunity for All U.S. EmployersThe new policy presents significant challenges for companies of all sizes, from SMEs to large multinational corporations like Microsoft, which employ a large number of H-1B visa holders. Galaxy Payroll Group’s comprehensive suite of services, including EOR, international payroll outsourcing, and stablecoin settlements, offers scalable and flexible solutions tailored to meet the needs of businesses of all sizes. By leveraging these services, companies can continue to access skilled professionals globally, ensuring they remain competitive in the international talent market."Our services are designed to support companies across the spectrum, from SMEs to large multinational corporations," Mr. Lao noted. "By leveraging our EOR and payroll services, these companies can continue to access skilled professionals globally, ensuring they remain competitive in the international talent market."Galaxy Payroll Group is well-positioned to meet the growing demand for efficient, compliant, and cost-effective international workforce management solutions. With its specialized suite of services, including support for stablecoin settlements, Galaxy Payroll Group provides a comprehensive and flexible solution to help companies navigate the complex global employment landscape. Galaxy Payroll Group remains committed to providing innovative and compliant solutions to support companies in their global talent management strategies.About Galaxy Payroll Group LimitedGalaxy Payroll Group Limited is a leading payroll outsourcing service provider based in Hong Kong. The company specializes in delivering HR and payroll solutions to multinational companies across various industries. With a focus on innovation and client satisfaction, GLXG operates in Hong Kong, Taiwan, Macau, and the PRC, offering payroll outsourcing, employment services, and consultancy to businesses of all sizes.For more information, please visit Galaxy Payroll Group's website: www.galaxyapac.com.Forward-Looking StatementsMatters discussed in this press release may constitute forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements, which are other than statements of historical facts. The words "believe," "anticipate," "intends," "estimate," "potential," "may," "should," "expect" "pending" and similar expressions identify forward-looking statements. The forward-looking statements in this press release are based upon various assumptions. Although we believe that these assumptions were reasonable when made, because these assumptions are inherently subject to significant uncertainties and contingencies which are difficult or impossible to predict and are beyond our control, we cannot assure you that we will achieve or accomplish these expectations.For enquiry, please contact Intelligent Joy Limited:Karen DengPhone:(852) 3594 6407Email: pr-team@intelligentjoy.com Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

BANGKOK, Sept 26, 2025 - (ACN Newswire via SeaPRwire.com) - SCGJWD Logistics PCL (SET: SJWD), the largest integrated logistics and supply chain service provider in ASEAN, is further expanding its cold storage warehouse business, increasing coverage from the CLMV + China group of countries to Indonesia, the Philippines, Malaysia and Singapore. This enlarged regional cluster reinforces the Company's position as a strong Cold Chain Hub in ASEAN, capitalizing on the growth of cold storage in the region and leveraging cold storage as a growth driver for the core business.SCGJWD Logistics Co-CEOs: Mr. Bunn Kasemsup (L) and Mr. Charvanin Bunditkitsada (R)Mr. Bunn Kasemsup, Co-CEO of SCGJWD Logistics, remarked that the Company recognized the economic growth potential in Indonesia, the Philippines, Malaysia and Singapore as leading ASEAN countries driving regional economies. "We are expanding our cold storage warehouse and temperature-controlled transport business from the 'CLMV + China' group of countries (Cambodia, Lao PDR, Myanmar, Vietnam + China) to these Southeast Asian countries to enhance our position as a Cold Chain Hub in ASEAN – a strong center of the cold storage warehouse business in ASEAN, including the creation of a regional cold storage warehouse clusters."SCGJWD has invested in logistics services in Indonesia since 2017 through joint venture PT SCG Barito Logistics, and is capable of providing country-wide logistics services, covering the major islands of Java, Sumatra, Kalimantan, Sulawesi, Bali, and Maluku. Services include land transport, general warehousing and dangerous goods storage, with a fleet of more than 200 trucks. In 2025, SCGJWD expects to realize a revenue of US$45 million, an 8% year-on-year increase, mainly from serving customers within the SCGJWD Group and Thai companies investing in Indonesia. SCGJWD has also entered into a joint venture with the Samudera Group, a major Indonesian shipping line operator, to manage cold storage warehouses, and is in negotiations for a business collaboration with a major Indonesian cold storage warehouse operator, which runs seven cold storage warehouses with a combined capacity of 30,000-40,000 pallets.In the Philippines, SCGJWD partnered with Royal Cargo, Inc (RCI), a leading integrated logistics and cold storage service provider in the country, to establish SCG Logistics Philippines Co., Ltd., a joint venture in 2023. SCGJWD recognized growth opportunities in the cold storage business in the Philippines and the potential in Royal Cargo, which operates over 140,000 square meters of cold storage space, capable of accommodating over 33,000 pallets. Discussions are currently underway to further expand investment in the Philippines.Malaysia was the latest country SCGJWD has invested in, partnering with Swift Haulage Berhad (SWIFT), a major integrated logistics service provider listed on the Malaysian Stock Exchange, to establish joint venture Swift Cold Chain Sdn Bhd to invest in three cold storage warehouse projects. These are: (1) The GVL Cold Chain project, within Shah Alam International Logistics Hub covering approximately 11,000 m2 with a 10,000 pallet capacity. Construction is expected to be completed in Q4 2025 for service in early 2026; (2) The cold storage warehouse project in Johor Bahru covering 10,000 m2 with a 10,000 pallet capacity. Preparations to start construction are currently under way and are expected to be completed in Q4 2026. Both these projects will require a total investment of more than 800 million baht; (3) The cold storage warehouse construction project in Penang, with an area of 10,000 to 20,000 m2. This project is expected to be finalized in Q1 2027."SCGJWD prioritizes the expansion of its logistics clusters in Indonesia, the Philippines, Malaysia, and Singapore, all of which are leading ASEAN countries with high growth potential. However, due to their archipelago-like geography, freight transport requires expertise and a truly comprehensive service network including solutions to meet the specific needs and addressing logistics and supply chain issues for customers. Therefore, we offer a wide range of services, including land, rail, and water transport; cold storage; general warehousing; and international freight forwarding, to meet the logistics needs of customers in each country and to ship goods from Singapore to Malaysia, the Philippines, or Indonesia," Mr Bunn said.Mr. Charvanin Bunditkitsada, Co-CEO of SCGJWD, stated that the 'CLMV + China' markets are strategically important for SCGJWD's cold storage business, with a broad market base covering both domestic consumption and import-export markets. This collaboration enables SCGJWD to connect and enhance its cross-border transportation services for temperature-controlled goods and general goods on the Thailand-ASEAN-China route. This has also led SCGJWD to adapt its transportation models and routes, including providing cross-border transportation services from other countries to Cambodia during the border closure period.SCGJWD, in collaboration with its partner RMA, has expanded its cold storage warehouse in Cambodia by 1,200 m2, bringing the total floor area to 3,400 m2, with an investment of US$550,000 (approximately 17.5 million baht). Recently, the Company partnered with Express Food Group (EFG), Cambodia's major operator of food chain franchises, including The Pizza Company, Dairy Queen, and Swensen's, to import and transport cooking equipment from Thailand to Cambodia. The Company offered a solution during border closure by adjusting the transportation route through Laos and Vietnam to Cambodia, as well as by sea routes. Furthermore, the Company provided services to 'TOUS les JOURS', a customer of EFG, to transport baking ingredients from Vietnam to its 6-7 branches in Cambodia. The Company also plans to expand its logistics services through a collaboration with its Vietnamese partner Transimex, which is a comprehensive end-to-end logistics provider, to supply temperature-controlled freight services for BigC.SCGJWD's goal is to make cold storage and temperature-controlled transportation a core growth driver, which aligns with the overall projection of the cold storage business in ASEAN from 2022 to 2027. A good example is Indonesia, whose total cold storage market is expected to increase by nearly 80%, from US$6.9 to US$12.5 billion. The Philippines' market is likewise expected to increase by 46.5% from US$5 to US$7.4 billion. Malaysia's market is expected to increase by 29.5% from US$1.836 to US$2.377 billion, and Singapore's market is forecast to increase by 25.6 percent from US$829 million to US$1.041 billion, while Vietnam's market is projected to increase by 47.2% from US$4.3 to US$6.4 billion, and Thailand's market is expected to increase by 38.7% from US$3.4 to US$4.7 billion.In Thailand, SCGJWD is currently expanding its investment in ten cold storage warehouses in six provinces, covering strategic industrial areas of Samut Sakhon, Samut Prakan, Pathum Thani, Chachoengsao, and Saraburi, as well as the northern province of Chiang Mai, with a combined floor area of over 160,000 square meters, able to support over 100,000 tons of goods or 240,000 pallets. Plans are also afoot to expand investment in Surat Thani and Khon Kaen provinces to increase service potential to ultimately cover all regions of Thailand.For more information, please visit https://www.scgjwd.com/en Press release by MT Multimedia Co Ltd for SCGJWD Logistics PCL.For more information, please contact:Thiyaporn Sriadunphan (Dah)Tel: +66 87 556 6974E-mail: thiyaporn.s@mtmultimedia.comAbout SCGJWD Logistics PCL (SET: SJWD)SCGJWD Logistics PCL was created when SCG Logistics Management Co Ltd and JWD InfoLogistics PCL, two leading logistics and supply chain service providers at the ASEAN level, together announced a merger deal on Oct 24, 2022, to become the largest Integrated Logistics and Supply Chains Solutions Provider in ASEAN. Formally recognized on Feb 24, 2023, the Company is jointly managed by Co-Chief Executive Officers (Co-CEOs) Mr. Bunn Kasemsup, representing SCGL, and Mr. Charvanin Bunditkitsada, representing JWD. (SET: SJWD) https://www.scgjwd.com/en Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Nanning, China, Sept 26, 2025 - (ACN Newswire via SeaPRwire.com) - The 22nd China-ASEAN Expo (CAEXPO) took place in Nanning, Guangxi, China, from September 17 to 21, 2025. Nanning Rail Transit Investment Group served as a bridge for regional cooperation through diversified approaches such as project agreements, technology export, and cooperation and exchanges, showcasing the comprehensive strength of state-owned enterprises and delivering significant achievements.During the CAEXPO this year, the Group signed three cooperation projects with JD.com and other enterprises, with a total investment of RMB 850 million, covering the fields of green energy and artificial intelligence (AI). The Group also joined hands with the Shenzhen Institute of Computing Sciences and Funeng Technology Holdings (Shenzhen) Co., Ltd. to establish the "Intelligent Transportation AI Data Joint Laboratory," integrating resources from all three parties to explore innovative smart rail transit applications and advance the commercialization of scientific and technological achievements. Leveraging the ASEAN Metro Cooperation Committee of the China Association of Metros, the "China-ASEAN Rail Transit Training Base" was officially inaugurated. This initiative integrates resources from the government, enterprises, and schools to cultivate high-quality rail transit professionals who possess both expertise and an international perspective, drive innovation in smart rail transit technologies, and facilitate the commercialization of achievements, thereby deepening collaboration between China and ASEAN in the rail transit sector. As the host enterprise, the Group also organized the 2nd China-ASEAN International Seminar on Railway Interconnectivity Standardization, actively establishing a regional platform for talent cultivation and joint standard-setting. At the Nanning-Hanoi Economic Corridor and the "Belt and Road" Nanning Friendship Cities Exchange Conference, the Group developed a customized "MaaS Smart Mobility+" solution to meet the needs of Khon Kaen, Thailand, for an integrated smart transportation system (Model as a Service, MaaS), providing tailored solutions for smart transportation across ASEAN. The "Guangxi AI + Low-altitude Economy Industry-Education Integration Community" was inaugurated, which marked a deepened collaboration among the government, industry, colleges and universities, research institutes, and users. The ASEAN 10-country, multilingual, real-time translation AI-powered intelligent and digital subway customer service system, jointly developed with Unisound, also drew significant attention during the CAEXPO. During the CAEXPO, delegations from 12 government and business associations representing seven countries, including the United Kingdom, Myanmar, and Vietnam, visited and conducted on-site inspections of key facilities, such as the Network Operations Command Center (NOCC), the Intelligent Operations and Maintenance Center, and the Nanning Railway S&T Innovation Industrial Park. They gave high praise to Nanning subway's efficient and intelligent operations and its 99.99% train punctuality rate, commending it as a benchmark for ASEAN rail transit operations.Established in 2008, Nanning Rail Transit Investment Group comprises 77 subsidiaries at various levels and employs more than 12,000 people. The Group has been repeatedly recognized as an "Excellent Enterprise in Guangxi" and listed among the "Top 100 Enterprises in Guangxi." Currently, the Group operates five subway lines that extend a total of 128.2 kilometers. In the first half of 2025, passenger ridership exceeded 187 million, with a passenger density of 8,300 individuals per kilometer per day, which ranked the Group 12th among 53 subway operators nationwide.In terms of industrial layout, the Group has established a coordinated model integrating rail transit construction and operation, equipment manufacturing, digital economy, and urban development. Its Nanning Rail Transit Intelligent Manufacturing Industrial Park and Nanning Railway S&T Innovation Industrial Park have attracted nearly 50 high-end enterprises, forming an industrial cluster. The Group's independently developed intelligent operation and maintenance system, protected by 54 patents, serves more than 70 lines across 14 cities in China. In the realm of smart cities, the Group has developed a smart platform enabling seamless integration between public transportation and shared mobility, advancing the MaaS model through "industrial investment + digital services." The "Nanning Railway One-Code Access" and "Nanning Railway APP" have served over 8 million users, facilitating over 10 billion travel scenario connections.At present, the Group has built an investment-construction-operation-management integrated system encompassing all aspects of rail transit, including design, construction, operation, consulting, maintenance, equipment manufacturing, and talent cultivation. It can provide comprehensive solutions throughout the entire chain and continues to contribute to the high-quality development of China-ASEAN rail transit and the advancement of the Belt and Road Initiative (BRI).Company: Nanning Rail Transit Investment Group Co., Ltd.Email: gdtzwx1@nngdjt.com Website: http://www.nngdjt.com Telephone: +86 771 2332897 Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com